IRF4 and colorectal carcinoma: To explore whether increasing the number of DMRs improves sensitivity for early stage CRC, we redesigned the methylation-specific ctDNA qPCR assay to include an additional DMR target in IRF4 and changed the IKZF1 PCR assay component to detect the targeted DMR on both strands [11, 12].